Arena Stock Hits New 52-Week Low (ARNA)
NEW YORK (
) --
(Nasdaq:
) hit a new 52-week low Friday as it is currently trading at $6.91, below its previous 52-week low of $6.95 with 2.1 million shares traded as of 9:56 a.m. ET. Average volume has been 5.7 million shares over the past 30 days.
Arena has a market cap of $1.61 billion and is part of the health care sector and drugs industry. Shares are down 17.8% year to date as of the close of trading on Wednesday.
Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates
Arena
as a
. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. You can view the full
.
See all
or get investment ideas from our
.
.
null